Return on Equity (ROE)
Updated 246h ago
Sector Performance
67th percentileWMB
19.7%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how efficiently a company generates profit from every dollar of shareholders’ equity—at 19.7%, WMB earns nearly 20 cents for each dollar of equity.
This exceeds the sector median of 13.8%, placing the firm in the 66th percentile among its peers. While the year-over-year change is not available, the metric fell 3.4% quarter-over-quarter from 20.4% to 19.7%, with no clear trend direction over the last eight quarters. The current ROE remains above average, but the recent decline suggests tightening efficiency rather than accelerating performance. For investors, this combination of a strong level with a negative short-term move signals a moderate opportunity with a growing risk of slowing returns. This metric supports the overall CAUTIOUS verdict because the elevated ROE is under pressure from the quarterly drop, warranting a watchful stance.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about WMB?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are WMB's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master WMB's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full WMB research report →WMB
19.7%
Sector Median
13.8%
Sector Avg
31.4%
How WMB's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.